Shanaka Stanislaus

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

Jing Xu, David J. Lloyd, Clarence Hale et al. · Diabetes · 2008 · 1.1K citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects

Jing Xu, Shanaka Stanislaus, Narumol Chinookoswong et al. · American Journal of Physiology-Endocrinology and Metabolism · 2009 · 338 citations

Medicine, Endocrinology, Pharmacology +17

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

Murielle M. Véniant, Shu-Chen Lu, Larissa Atangan et al. · Nature Metabolism · 2024 · 188 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance

Clarence Hale, Michelle Chen, Shanaka Stanislaus et al. · Endocrinology · 2011 · 180 citations

Life Sciences, Biochemistry, Endocrinology +17

Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes

Randy Hecht, Yuesheng Li, Jeonghoon Sun et al. · PLoS ONE · 2012 · 166 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +16